Natera, Inc.
(NASDAQ GS: NTRA)
Rigrodsky Law, P.A. is investigating Natera, Inc. (“Natera” or the "Company”) and certain of its officers for issuing materially false and misleading statements during the Class Period (February 26, 2020 and April 19, 2022, inclusive) concerning the Company’s non-invasive prenatal test, Panorama, and Natera’s screening test for kidney transplant failure, Prospera, in possible violation of the federal securities laws.